Description
packaging 50 pcs
Pharmacological action
Bromhexine has a mucolytic (secretolytic) and expectorant effect. The mucolytic effect is associated with the depolymerization and liquefaction of mucoprotein and mucopolysaccharide fibers.
Bromhexine has a mild antitussive effect. It stimulates the production of endogenous surfactant, which ensures the stability of alveolar cells during respiration. The clinical effect is manifested after 2-5 days from the start of treatment with the drug.
Pharmacokinetics
When taken orally, bromhexine is almost completely absorbed (99%) within 30 minutes. Bioavailability is 20-25% (effect of the first passage through the liver). In plasma, bromhexine firmly binds to 95% proteins, penetrates the blood-brain and placental barriers.
In the liver, bromhexine undergoes demethylation and oxidation. The half-life is 15 hours due to slow back diffusion from the tissues. It is excreted by the kidneys. In chronic renal failure, the excretion of bromhexine metabolites is impaired. With repeated use, bromhexine can accumulate.
Indications
Chronic inflammatory diseases of the lungs (bronchial asthma, cystic fibrosis, tuberculosis, tracheobronchitis, spastic bronchitis, bronchiectasis, pulmonary emphysema, pneumoconiosis), chest injuries, pre- and postoperative period.
Contraindications
Pregnancy (I trimester), children’s age (up to 3 years).
Use during pregnancy and lactation
During pregnancy and lactation, bromhexine is used in cases where the intended benefits to the mother outweigh the potential risk to the fetus or baby.
Composition
1 tablet contains:
Active ingredient:
bromhexine hydrochloride 4 mg
Excipients:
lactose,
sucrose,
potato starch,
sodium carbohydrate.
Dosage and administration
Inside, 3 times a day, with water if necessary.
Adults and adolescents over 14 years of age: 8 16 mg or 2 3 teaspoons.
For children from 6 to 14 years: 4 8 mg or 1 2 teaspoons.
For children under 6 years: recommended syrup, up to 2 years – 1/2 teaspoon, from 2 to 6 years – 1/2 / 1 teaspoon.
Side effects of the
Digestive system: dyspeptic symptoms, transient increase in the activity of hepatic transaminases in the blood serum.
From the side of the central nervous system: headache, dizziness.
Dermatological reactions: increased sweating, skin rash.
From the respiratory system: cough, bronchospasm.
Drug Interaction
Bromhexine can be prescribed at the same time as other drugs used in the treatment of bronchopulmonary diseases.
Bromhexine is not prescribed at the same time as anti-cough agents (including codeine), because they can make it difficult to clear the sputum of Bromhexine.
Bromhexine promotes the penetration of antibiotics (amoxicillin, erythromycin, cephalexin, oxytetracycline), sulfanilamide drugs into the bronchial secretion in the first 4-5 days of antimicrobial therapy.
Bromhexine is not compatible with alkaline solutions.
overdose
Symptoms:
nausea, vomiting, diarrhea, dyspeptic disorders.
Treatment:
artificial vomiting, gastric lavage (in the first 1-2 h after admission).
Storage conditions
Store at room temperature up to 25 ° C.
Keep out of the reach of children.
Expiration
5 years.
Deystvuyuschee substances
Bromhexine
pharmacy dispensing terms Over the counter
Dosage
form Dosage form
tablets
